Q2 EPS Estimate for Acadia Healthcare Reduced by Analyst

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Investment analysts at Zacks Research reduced their Q2 2026 earnings per share estimates for shares of Acadia Healthcare in a report released on Wednesday, May 13th. Zacks Research analyst Team now expects that the company will post earnings per share of $0.35 for the quarter, down from their prior estimate of $0.49. Zacks Research currently has a “Hold” rating on the stock. The consensus estimate for Acadia Healthcare’s current full-year earnings is $1.49 per share. Zacks Research also issued estimates for Acadia Healthcare’s Q3 2026 earnings at $0.49 EPS, FY2026 earnings at $1.46 EPS, Q1 2028 earnings at $0.24 EPS and FY2028 earnings at $1.76 EPS.

Other analysts have also issued research reports about the company. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Acadia Healthcare in a report on Wednesday, January 21st. Raymond James Financial raised Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 price objective for the company in a report on Monday, May 4th. Barclays lifted their price objective on Acadia Healthcare from $20.00 to $25.00 and gave the stock an “equal weight” rating in a report on Thursday, April 30th. Guggenheim lifted their price objective on Acadia Healthcare from $26.00 to $31.00 and gave the stock a “buy” rating in a report on Monday, May 4th. Finally, Cantor Fitzgerald lifted their price objective on Acadia Healthcare from $20.00 to $30.00 and gave the stock a “neutral” rating in a report on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, seven have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Acadia Healthcare presently has an average rating of “Hold” and an average target price of $26.04.

Acadia Healthcare Stock Performance

Shares of ACHC opened at $27.15 on Thursday. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.71 and a quick ratio of 1.71. Acadia Healthcare has a one year low of $11.43 and a one year high of $30.20. The firm has a market capitalization of $2.50 billion, a P/E ratio of -2.22, a PEG ratio of 8.73 and a beta of 0.73. The business has a fifty day moving average of $25.17 and a 200 day moving average of $19.19.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Wednesday, April 29th. The company reported $0.37 EPS for the quarter, topping analysts’ consensus estimates of $0.28 by $0.09. Acadia Healthcare had a positive return on equity of 7.09% and a negative net margin of 32.84%.The business had revenue of $828.80 million during the quarter, compared to analyst estimates of $823.51 million. During the same quarter last year, the company earned $0.40 EPS. The company’s quarterly revenue was up 7.6% compared to the same quarter last year. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS.

Institutional Trading of Acadia Healthcare

Hedge funds have recently bought and sold shares of the stock. EverSource Wealth Advisors LLC grew its holdings in Acadia Healthcare by 54.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock valued at $32,000 after purchasing an additional 497 shares during the period. Wells Fargo & Company MN grew its holdings in Acadia Healthcare by 208.9% during the fourth quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock valued at $32,000 after purchasing an additional 1,510 shares during the period. Bayforest Capital Ltd bought a new stake in Acadia Healthcare during the fourth quarter valued at about $52,000. Hantz Financial Services Inc. grew its holdings in Acadia Healthcare by 501.9% during the third quarter. Hantz Financial Services Inc. now owns 2,185 shares of the company’s stock valued at $54,000 after purchasing an additional 1,822 shares during the period. Finally, GAMMA Investing LLC grew its holdings in Acadia Healthcare by 124.7% during the fourth quarter. GAMMA Investing LLC now owns 4,862 shares of the company’s stock valued at $69,000 after purchasing an additional 2,698 shares during the period.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.